Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

24 Jan, 2020, 14:30 GMT Lipidor Announces Positive Topline Results of AKP01 Phase III Clinical Study Using Calcipotriol Spray Against Psoriasis

Lipidor AB (Nasdaq First North: LIPI) today reports positive topline results of its AKP01 Phase III clinical study, using calcipotriol spray against...


23 Jan, 2020, 13:45 GMT World Health Organization Accelerating Diagnostics, Vaccines, Therapeutics For Novel Coronavirus

Since The Chinese authorities identified a new type of coronavirus, (novel coronavirus 2019-nCoV) from Wuhan, Hubei Province, China, which was...


23 Jan, 2020, 09:10 GMT iOnctura Raises EUR 15 Million in Series A Financing to Progress its Pipeline into Clinical Development

iOnctura B.V., a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis,...


23 Jan, 2020, 00:01 GMT New Clinical Trial Proves Allen Carr's Easyway to Stop Smoking Seminars Are at Least as Effective as the UK's Gold Standard NHS Stop Smoking Service

The largest and most authoritative research trial of its kind has confirmed that Allen Carr's Easyway (ACE) is now a clinically proven, highly...


22 Jan, 2020, 13:00 GMT Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration on...


22 Jan, 2020, 07:13 GMT Positive Opinion Received From EMA Paediatric Committee on the Paediatric Investigation Plan for Nefecon for the Treatment of IgAN

Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the EMA Paediatric Committee (PDCO) has adopted a positive opinion on the...


21 Jan, 2020, 16:18 GMT Targovax Announces Encouraging Data in Mesothelioma Study Combining ONCOS-102 and Standard of Care Chemotherapy

Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today announces ...


21 Jan, 2020, 14:00 GMT US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory multiple myeloma

GlaxoSmithKline plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) granted a priority review for the company's Biologics License ...


21 Jan, 2020, 10:19 GMT Diaprost Announces Exercise of Option Under the Terms of its Research and Option Agreement With a Leading Pharmaceutical Company

Diaprost entered into an exclusive Research and Option Agreement with a Top 10 Pharmaceutical company strategic partner in October 2017. Diaprost now ...


21 Jan, 2020, 10:00 GMT OBI Pharma Granted U.S. FDA Orphan Drug Designation for the Treatment of Gastric Cancer for Its Antibody-Drug Conjugate (ADC) Targeted Cancer Therapy, OBI-999

OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug...


20 Jan, 2020, 15:41 GMT Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the European Commission approved Sunosi® (solriamfetol) to improve wakefulness and...


20 Jan, 2020, 03:05 GMT China-Based Ivy Capital Invests in Betagenon's Clinical Stage AMPK Activator Program

Balticgruppen Bio, the Umeå based Biotech company focused on development of AMPK activator compounds, operating under the trademark Betagenon, has...


16 Jan, 2020, 14:00 GMT New Study Indicates 'Helper' Cells May Kill Cancerous Tumors

USA News Group – A new study out suggests that T cells are a subset of lymphocytes (white blood cells), which play a key role in the body's immune...


15 Jan, 2020, 16:31 GMT BerGenBio Meets Efficacy Endpoint For First Stage Of Phase II Trial With AXL Inhibitor Bemcentinib in Combination With Keytruda® in NSCLC Patients Progressing on Immune Checkpoint Inhibitors

BerGenBio ASA (OSE: BGBIO) a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer...


15 Jan, 2020, 12:15 GMT HKBU Scientists Invent New Chemical Method for Cordyceps sinensis Authentication

A Chinese medicine research team at Hong Kong Baptist University (HKBU) has identified a unique polysaccharide marker from the caterpillar part of...


14 Jan, 2020, 11:00 GMT Marken Announces European Center Of Excellence

Marken has launched a new European Communication Center of Excellence based in Edinburgh designed to enrich the overall supply chain experience by...


14 Jan, 2020, 07:00 GMT Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer

Genome & Company (KONEX: 314130) is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, ...


14 Jan, 2020, 07:00 GMT Phagenesis Receives FDA Breakthrough Device Designation for Its Phagenyx® System to Accelerate Removal of the Breathing Tube by Treating Neurogenic Dysphagia

Phagenesis Ltd., a pioneering leader in the treatment of dysphagia, is pleased to announce today that the company has received Breakthrough Device...


14 Jan, 2020, 00:05 GMT Sosei Heptares: Significant Progress by Orexia and Inexia With Orexin Agonist Program Triggers Next Tranche of Funding From Medicxi

Sosei Group Corporation ("the Company") (TSE: 4565) announces that significant scientific progress at its spin-off companies Orexia Limited...


13 Jan, 2020, 12:00 GMT Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting Pelareorep's Unique Ability to Activate the Immune System in Late Stage Multiple Myeloma

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) (TSX: ONC.TO), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, ...


13 Jan, 2020, 10:42 GMT COMPASS Pathways Granted Patent Covering Use of Its Psilocybin Formulation in Addressing Treatment-resistant Depression

COMPASS Pathways, a mental health care company, announced today that it has been granted US Patent No 10,519,175, relating to methods of treating...


10 Jan, 2020, 12:23 GMT RhoVac Receives Approval in Germany and Belgium to Start Clinical Phase IIb Study in Prostate Cancer

RhoVac AB ("RhoVac") announces today, on 10th January 2020, that the company has received approval from Beligian FAMHP (Federal Agency for Medicines...


09 Jan, 2020, 12:00 GMT Oncolytics Biotech® Announces Key Opinion Leader Call Conducted by ROTH Capital Partners to Discuss Multiple Myeloma

ncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today...


09 Jan, 2020, 12:00 GMT Debiopharm: Novadiscovery Raises Series A Financing to Scale its in silico Clinical Trial Platform - Debiopharm Leads the Round With EUR 5 Million

The French health-tech company Novadiscovery, which performs in silico trials for pharma and biotech companies with the aim of reducing research &...


09 Jan, 2020, 10:36 GMT AMO Pharma Announces Initiation of Planned Pivotal Clinical Trial for Myotonic Dystrophy Following $35m Fund Raise

AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood-onset neurogenetic disorders with limited...